Pfizer Inc logo

Pfizer Inc

PFE
Healthcare|Drug Manufacturers - General|USA
$27.83
-0.49 (-1.73%)
DCF (FCF)
$43.06
Earnings Power
$22.11

Upcoming Data Readouts (45)

Oct 2026
Est. completion
P2Atopic Dermatitis
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
Oct 2026
Est. completion
P4Migraine Headaches
Acute Migraine Treatment in the ED With Gepants
Dec 2026
Est. completion
Invasive Fungal Disease
FungiScope - A Global Emerging Fungal Infection Registry
Dec 2026
Est. completion
NAProstate Cancer
ASCVD Management Using CCTA in Prostate Cancer Patients on ADT
Dec 2026
Est. completion
P1Healthy Participants
A Study to Learn How the Body Processes the Study Medicine Called Vepdegestrant in People With Loss of Liver Function
Dec 2026
Est. completion
P2Urothelial Carcinoma
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Dec 2026
Est. completion
P2Lymphoma, Non-Hodgkin
Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)
Dec 2026
Est. completion
P4Metastatic Urothelial Carcinoma
A Safety Study of Enfortumab Vedotin in Indian Adults With Urothelial Cancer
Jan 2027
Est. completion
P2Mycosis Fungoides
Effectiveness of Concurrent Ultra-Low-Dose Total-Skin Electron Beam Therapy and Brentuximab Vedotin Given Quarterly Over 12 Months for Patients With Mycosis Fungoides
May 2027
Est. completion
P1Melanoma
A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors
Jun 2027
Est. completion
P1Carcinoma, Non-Small Cell Lung
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Jul 2027
Est. completion
P1Myelodysplastic Syndrome
A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies
Jul 2027
Est. completion
Respiratory Syncytial Viruses
Effectiveness of ABRYSVO® Maternal Respiratory Syncytial Virus (RSV) Vaccine Against RSV in Infants in Western Pennsylvania
Aug 2027
Est. completion
P1Acute Treatment of Migraine
A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
Sep 2027
Est. completion
P2Cancer
The Drug Rediscovery Protocol (DRUP Trial)
Dec 2027
Est. completion
P3ISS
Comparison of Weekly Somatrogon to Daily Genotropin in Children Born Small for Gestational Age or With Idiopathic Short Stature.
Dec 2027
Est. completion
P2Prostate Adenocarcinoma
Effects of Relugolix vs Leuprolide on Cardiac Function in Patients With Prostate Cancer
Dec 2027
Est. completion
P2Lymphoma, Non-Hodgkin
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Dec 2027
Est. completion
P1Metastatic Breast Cancer
Phase 1b Study of OP-1250 (Palazestrant) in Combination With Ribociclib, Alpelisib, Everolimus, or Atirmociclib in ER+, HER2- Breast Cancer
Dec 2027
Est. completion
Advanced Breast Cancer
Southeast Netherlands Advanced Metastatic Breast Cancer Registry

Awaiting Results (29)

Trials past primary completion date but still active — data readout may be imminent.

Sep 2026
P2
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
NCT04557449
Sep 2026
P1P2
TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study A)
NCT05548127
Sep 2026
NA
Role of Immune System in Obesity-related Inflammation and Cardiometabolic Risk
NCT01104220
Jun 2026
P3
Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2
NCT05911295
Jun 2026
A Study to Learn About Lorlatinib in Patients With Non-Small Cell Lung Cancer (NSCLC) Which Has Spread Out.
NCT06678555
Jun 2026
P1P2
Study to Evaluate Sacituzumab Govitecan in Combination With Talazoparib in Patients With Metastatic Breast Cancer.
NCT04039230
May 2026
P2
A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2
NCT06003231
Mar 2026
P1P2
Safety and Efficacy of Tisotumab Vedotin Monotherapy & in Combination With Other Cancer Agents in Subjects With Cervical Cancer
NCT03786081
Mar 2026
P1
A Clinical Trial of PF-08046037 Alone or With Sasanlimab in Patients With Advanced or Metastatic Malignancies
NCT06974734
Mar 2026
P2
Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors
NCT03485209

Recent Press Releases